Search

everythinglearnresearchcommunity

for

Search:↓

The research confirms that Hidradenitis Suppurativa is characterized by increased inflammation, disrupted skin cell organization, and abnormal metabolic processes.

miR-199a-3p controls hair growth and is linked to alopecia areata.

Some COVID-19 patients have different skin problems, which might be the only sign of the virus or related to other health issues.

Using multiple treatments together works better for female hair loss than using one treatment alone.

The study identified key genes and pathways linked to hair disorders, aiding precision medicine.

Hair follicles are essential for skin health, aiding in hair growth, wound healing, and immune function.

Targeting multiple pathways may improve treatments for androgenetic alopecia.

Periplaneta americana extract helps hair regrowth by reducing inflammation and improving skin bacteria balance.

Blocking certain pathways with kinase inhibitors may help treat cutaneous lupus erythematosus.

The combined treatment with engineered bacteria and yellow LED light improved wound healing in mice.

Similar treatments might work for different types of scarring hair loss.

Blocking JAK1 or JAK3 helps reverse hair loss in a mouse model of alopecia areata.

IL-17 is more important than IFN-γ in causing severe hair loss in chronic alopecia areata.

Arg1+ macrophages may play a role in Alopecia Areata, offering new treatment targets.

The study found key factors in the cause of hidradenitis suppurativa, its link to other diseases, and identified existing drugs that could potentially treat it.

Corticosteroid treatment reduces inflammation and alters hair keratins in alopecia areata.

Accurate diagnosis and new therapies are crucial for effectively treating certain types of hair loss.

Improving blood vessel health and controlling uric acid may help manage alopecia areata.

CBD can help hair grow by supporting scalp health and reducing inflammation.

UVA exposure worsens hair loss by activating a specific cell pathway.

Alopecia areata is an autoimmune condition causing hair loss, linked to genetic factors and immune system issues, with no cure yet.

PTCH gene mutations contribute to basal cell carcinoma development.

Male pattern baldness involves hormones and cell signals affecting hair growth.

Huaier helps hair grow back and repairs tissue after cancer treatment.

Upadacitinib effectively treated severe atopic dermatitis, vitiligo, and alopecia areata in one patient.

Upadacitinib may effectively treat both alopecia universalis and Crohn's disease.

The Fas/FasL pathway may play a role in alopecia areata.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Using three different drugs together may better treat eye diseases like glaucoma and macular degeneration.

Resolving malaria-related lung issues doesn't rely on Alox12 and leaves some inflammation.